Stoke Therapeutics
STOK
STOK
47 hedge funds and large institutions have $409M invested in Stoke Therapeutics in 2019 Q2 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$92.6M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$54.5M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$54.3M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$32.7M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$29.8M |
Top Sellers
No sellers this quarter
